Kun Jiang1, He-Bin Chen1, Ying Wang1, Jia-Hui Lin2, Yan Hu1, Yu-Rong Fang1. 1. Department of Respiratory Medicine, Wuhan Children's Hospital, Wuhan 430016, China. 2. Department of Otorhinolaryngology, Wuhan Children's Hospital, Wuhan 430016, China.
Abstract
OBJECTIVES: To investigate the changes in the levels of interleukin-17 (IL-17) and transforming growth factor beta 1 (TGF-β1) in serum and bronchoalveolar lavage fluid (BALF) and their clinical significance among children with asthma. METHODS: A total of 56 children with asthma were divided into moderate or severe asthma (n=37) and mild asthma groups (n=19) and 18 children without asthma were selected as the control group. Cells in BALF were counted under a microscope. The levels of IL-17 and TGF-β1 in serum and BALF were measured using enzyme-linked immunosorbent assay (ELISA). RESULTS: There were no significant differences in total cell count and percentage of macrophages between the two asthma groups and the control group (P>0.05). The percentages of neutrophils, eosinophils and epithelial cells in BALF were significantly higher in the two asthma groups than in the control group (P<0.05). The two asthma groups had significantly higher levels of IL-17 and TGF-β1 in serum and BALF than the control group (P<0.05), and the moderate or severe asthma group had significantly higher levels of IL-17 and TGF-β1 in serum and BALF than in the mild asthma group (P<0.05). The serum levels of IL-17 and TGF-β1 were positively correlated with those in BALF (r=0.935 and 0.943, both P<0.05). In children with asthma, serum IL-17 level was positively correlated with the percentages of neutrophils, eosinophils, and epithelial cells in BALF (r=0.802, 0.799, and 0.674, all P<0.05), and a positive correlation was also seen between serum levels of IL-17 and TGF-β1 (r=0.878, P<0.05). CONCLUSIONS: Levels of IL-17 and TGF-β1 in serum and BALF are elevated in children with asthma. IL-17 and TGF-β1 may be involved in the occurrence and development of asthma, and they play important roles in asthma attack and aggravation.
OBJECTIVES: To investigate the changes in the levels of interleukin-17 (IL-17) and transforming growth factor beta 1 (TGF-β1) in serum and bronchoalveolar lavage fluid (BALF) and their clinical significance among children with asthma. METHODS: A total of 56 children with asthma were divided into moderate or severe asthma (n=37) and mild asthma groups (n=19) and 18 children without asthma were selected as the control group. Cells in BALF were counted under a microscope. The levels of IL-17 and TGF-β1 in serum and BALF were measured using enzyme-linked immunosorbent assay (ELISA). RESULTS: There were no significant differences in total cell count and percentage of macrophages between the two asthma groups and the control group (P>0.05). The percentages of neutrophils, eosinophils and epithelial cells in BALF were significantly higher in the two asthma groups than in the control group (P<0.05). The two asthma groups had significantly higher levels of IL-17 and TGF-β1 in serum and BALF than the control group (P<0.05), and the moderate or severe asthma group had significantly higher levels of IL-17 and TGF-β1 in serum and BALF than in the mild asthma group (P<0.05). The serum levels of IL-17 and TGF-β1 were positively correlated with those in BALF (r=0.935 and 0.943, both P<0.05). In children with asthma, serum IL-17 level was positively correlated with the percentages of neutrophils, eosinophils, and epithelial cells in BALF (r=0.802, 0.799, and 0.674, all P<0.05), and a positive correlation was also seen between serum levels of IL-17 and TGF-β1 (r=0.878, P<0.05). CONCLUSIONS: Levels of IL-17 and TGF-β1 in serum and BALF are elevated in children with asthma. IL-17 and TGF-β1 may be involved in the occurrence and development of asthma, and they play important roles in asthma attack and aggravation.
Authors: E M Minshall; D Y Leung; R J Martin; Y L Song; L Cameron; P Ernst; Q Hamid Journal: Am J Respir Cell Mol Biol Date: 1997-09 Impact factor: 6.914
Authors: Rhonda H Wilson; Gregory S Whitehead; Hideki Nakano; Meghan E Free; Jay K Kolls; Donald N Cook Journal: Am J Respir Crit Care Med Date: 2009-08-06 Impact factor: 21.405
Authors: Laila A Al-Alwan; Ying Chang; Carolyn J Baglole; Paul-André Risse; Andrew J Halayko; James G Martin; David H Eidelman; Qutayba Hamid Journal: J Allergy Clin Immunol Date: 2012-06-13 Impact factor: 10.793
Authors: Harold Kim; Anne K Ellis; David Fischer; Mary Noseworthy; Ron Olivenstein; Kenneth R Chapman; Jason Lee Journal: Allergy Asthma Clin Immunol Date: 2017-11-17 Impact factor: 3.406